Work

A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer

Year: 2004

Type: article

Study design: Clinical Trial

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2004.01.002

Authors: Donald S. Kaufman, Michael A. Carducci, Tim M. Kuzel, Mary B. Todd, William K. Oh, Matthew R. Smith, Zhishen Ye, Steven J. Nicol, Walter M. Stadler

Institutions: Massachusetts General Hospital, Johns Hopkins Medicine, Johns Hopkins Hospital, Northwestern University, Rutgers Cancer Institute, Dana-Farber Cancer Institute, Eli Lilly (United States), University of Chicago

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, World Health Organization

OpenAlex ID: W1973341410

FWCI: 5.053

Cites: 16

Cited by: 61

Related to: 10